6.
Prognostic factors | Univariate | Multivariate | |||||
HR | 95% CI | P | HR | 95% CI | P | ||
OS, overall survival; SCC, squamous cell carcinoma; BMI, body mass index; FIGO, International Federation of Gynecology and Obstetrics; LNM, lymph node metastasis; LVSI, lymphovascular space invasion; HR, hazard ratio; 95% CI, 95% confidence interval. | |||||||
Age at diagnosis (year) (≥45 vs. <45) | 0.982 | 0.511–1.887 | 0.956 | – | – | – | |
BMI (kg/m2) (≥24 vs. <24) | 1.017 | 0.527–1.962 | 0.961 | – | – | – | |
FIGO stage (Ib vs. IIa) | 1.002 | 0.439–2.289 | 0.996 | – | – | – | |
Tumor size (cm) (≤4 vs.>4) | 1.075 | 0.544–2.124 | 0.835 | – | – | – | |
Differentiation (G1–G2 vs. G3) | 0.397 | 0.201–0.784 | 0.006 | 0.584 | 0.291–1.173 | 0.134 | |
LNM (+ vs. –) | 8.365 | 4.279–16.354 | 0.000 | 5.804 | 2.869–11.741 | 0.000 | |
Stromal invasion (≥1/2 vs. <1/2) | 2.118 | 1.097–4.091 | 0.022 | 1.310 | 0.666–2.576 | 0.465 | |
LVSI (+ vs. –) | 5.692 | 2.911–11.046 | 0.000 | 3.462 | 1.725–6.950 | 0.000 |